Healthcare Services

Therapeutic Plasma Exchange Market Forecast with Demand Insights

April 28, 2026April 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Therapeutic Plasma Exchange Market From 2026 To 2030?

The therapeutic plasma exchange market has experienced substantial growth in recent years. This market is set to expand from $1.61 billion in 2025 to $1.76 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.4%. Historically, this expansion can be ascribed to factors such as increased diagnosis of autoimmune disorders, the expansion of hospital transfusion services, the availability of centrifugation-based technologies, growing clinician familiarity with apheresis procedures, and the adoption of standardized treatment protocols.

The therapeutic plasma exchange market is anticipated to experience substantial expansion over the coming years. By 2030, its value is projected to reach $2.4 billion, advancing at a compound annual growth rate (CAGR) of 8.0%. This projected growth is driven by several factors, including the increasing need for sophisticated autoimmune therapies, the wider uptake of membrane separation technology, the expansion of outpatient apheresis provisions, increased capital directed towards blood purification innovations, and a stronger emphasis on individualized immunological care. Key trends anticipated during this period encompass the growing integration of automated plasma exchange systems, the increasing application of tpe in addressing neurological conditions, a rising requirement for highly efficient separation techniques, the broadening of apheresis units within hospitals, and a heightened commitment to ensuring treatment safety and diligent monitoring.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15683&type=smp

Which Drivers Are Supporting The Therapeutic Plasma Exchange Market Growth?

The widespread occurrence of hematological disorders is anticipated to propel the future growth of the therapeutic plasma exchange market. These medical conditions, also recognized as blood disorders, pertain to ailments affecting the blood and blood-forming tissues, including the bone marrow, lymph nodes, and spleen. The increase in hematological disorders stems from factors such as genetic predispositions, environmental influences, and lifestyle modifications. Therapeutic plasma exchange (TPE) is employed in hematological disorders to eliminate pathogenic substances from the plasma, for instance, autoantibodies in autoimmune hemolytic anemia or immune complexes in thrombotic thrombocytopenic purpura, thereby reducing disease severity and enhancing patient outcomes. For illustration, in July 2024, Cancer Research UK, a UK-based charity, reported that the average annual number of new Hodgkin lymphoma cases in the UK is expected to rise from approximately 2,400 cases in 2023-2025 to around 2,900 cases in 2038-2040. Consequently, the significant prevalence of hematological disorders is fueling the expansion of the therapeutic plasma exchange market.

How Is The Therapeutic Plasma Exchange Market Segmented Across Different Segment Categories?

The therapeutic plasma exchange market covered in this report is segmented –

1) By Type: Therapeutic Plasma Exchange (TPE), Double Filtered Plasmapheresis (DFPP)

2) By Indication: Neurological Disorders, Hematological Disorders, Renal Disorders, Metabolic Disorders, Other Indications

3) By Technology: Centrifugation, Membrane Separation

4) By End User: Blood Collection Centers, Hospitals And Clinics, Transfusion Centers, Other End Users

Subsegments:

1) By Therapeutic Plasma Exchange (TPE): Manual TPE, Automated TPE

2) By Double Filtered Plasmapheresis (DFPP): Single-Stage DFPP, Multi-Stage DFPP

Which Trends Are Expected To Impact The Therapeutic Plasma Exchange Market?

Leading companies in the **therapeutic plasma exchange market** are concentrating on developing automation, enhancing device safety, and improving system efficiency to boost clinical acceptance and streamline operations. Automation refers to the reliance on systems and technology to execute tasks automatically without constant human oversight. For example, in **November 2024**, Terumo BCT, a US-based medical device manufacturer, unveiled software update **V12.1** for its premier Spectra Optia Apheresis System, which enhances ease of use, strengthens cybersecurity, and optimizes workflow, including an automatic pump pause during single needle exchange and alarm reduction. The system supports therapeutic plasma exchange with an average plasma removal efficiency of **87 %**, a minimal extracorporeal volume of **141 mL**, and only **1.0 %** median platelet loss. This move towards advanced automation and device safety is increasing TPE utilization in hospitals and specialized clinics; however, high initial expenses and the need for trained personnel continue to restrict its adoption in environments with limited resources.

Which Organizations Play A Role In The Therapeutic Plasma Exchange Market Landscape?

Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Octapharma AG, Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc.

Get The Full Therapeutic Plasma Exchange Market Report:

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Where Is The Therapeutic Plasma Exchange Market Primarily Concentrated By Region?

North America was the largest region in the therapeutic plasma exchange market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Therapeutic Plasma Exchange Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Browse Through More Reports Similar to the Global Therapeutic Plasma Exchange Market 2026, By The Business Research Company

Convalescent Plasma Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Plasma Protein Therapeutics Market Report

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Blood Plasma Derivatives Market Report

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795